The Company announces that on 8 January 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1296 pence per share. Further details are set out below: ...
EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Agreement Newron and Myung In Pharm announce license agreement for evenamide in South Korea 09.01.2025 / 07:00 CET/CEST The issuer is solely ...
Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules SIKA POSTS RECORD SALES OF CHF 11.76 BILLION IN 2024 -- ...
The China stock market has moved higher in back-to-back sessions, collecting almost 25 points or 0.8 percent along the way. The ...
The Singapore stock market has moved higher in five straight sessions, gathering more than 100 points or 1.5 percent along the way.
Having assessed the situation on its core markets, the fit of the company's near-term development portfolio and the existing operating portfolio ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...
GMT/BST Britvic plc 7 January 2025 DIRECTOR/PDMR ...
Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth ...
Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: ...
ZenaTech signed the LOI shortly before the end of the year. The Company anticipates closing on the acquisition before the end of January 2025. "This acquisition is part of a larger strategy to expand ...
Gold prices moved to the downside during trading on Monday, extending the pullback seen during last Friday's session. Gold for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback